Goldan Keith A.

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$44,522.25
Insider Sells Quantity
6
Insider Sells Sum
$36,358.14

Insider Activity of Goldan Keith A.

According to the SEC Form 4 filings, Goldan Keith A., being in a position of

  1. Chief Financial Officer at Syndax Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 1250 shares for $25,037, and sold 0 shares,
    over all time since 2023-06-13, has bought 1250 shares for $25,037, and sold 577 shares for $12,873.

The largest purchase of all time was on 2024-06-14 and amounted to 1250 shares of Syndax Pharmaceuticals, Inc. for $25,037.

The largest sale of all time was on 2023-06-13 and amounted to 577 shares of Syndax Pharmaceuticals, Inc. for $12,873.

Biography of Goldan Keith A.

No biography is available at this moment.

2024-06-14PurchaseSyndax Pharmaceuticals, Inc.
SNDX
Chief Financial Officer
1,250
0.0015%
$20.03$25,037-2.24%
2023-06-13SaleSyndax Pharmaceuticals, Inc.
SNDX
Chief Financial Officer
577
0.0008%
$22.31$12,873-8.2%
2022-03-16SaleOptiNose, Inc.
OPTN
Chief Financial Officer
4,617
0.0056%
$2.11$9,742+16.19%
2021-12-16SaleOptiNose, Inc.
OPTN
Chief Financial Officer
580
0.0009%
$1.64$951+64.51%
2021-09-16SaleOptiNose, Inc.
OPTN
Chief Financial Officer
578
0.0011%
$2.79$1,612-7.04%
2021-06-17SaleOptiNose, Inc.
OPTN
Chief Financial Officer
576
0.0011%
$3.73$2,148-29.73%
2021-03-15SaleOptiNose, Inc.
OPTN
Chief Financial Officer
2,304
0.0044%
$3.92$9,032-27.39%
2020-09-23PurchaseOptiNose, Inc.
OPTN
Chief Financial Officer
5,000
0.0103%
$3.90$19,485-6.57%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.